<DOC>
	<DOCNO>NCT01556165</DOCNO>
	<brief_summary>Rasagiline develop treatment Parkinson 's Disease ( PD ) , monotherapy early PD patient treat levodopa , adjunct therapy levodopa levodopa-treated PD patient motor fluctuation . The rationale conduct study evaluate efficacy , tolerability , safety rasagiline compare placebo Chinese PD patient treat levodopa .</brief_summary>
	<brief_title>Rasagiline Early Parkinson 's Disease Patients Not Treated With Levodopa China</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Patients idiopathic PD . Patients Modified Hoehn Yahr stage &lt; 3 . Patients clinically significant unstable medical surgical condition would preclude his/her safe complete study participation . Patients clinically significant unstable vascular disease . Patients clinically significant psychiatric illness , include major depression , compromise ability provide consent participate fully study . Patients Mini Mental State Examination ( MMSE ) score ≤24 . Patients diagnosis melanoma history melanoma , suspicious lesion . Other inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Rasagiline</keyword>
	<keyword>Azilect</keyword>
	<keyword>Parkinson´s Disease</keyword>
	<keyword>Motor fluctuation</keyword>
</DOC>